Cellid, , Ltd. EBIT

As of the most recent data (June 2026), 299660.KQ shows a EBIT of $-11B. That compares with $-8.5B in the prior-year period — down 25.8% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 299660.KQ's EBIT is now $-11B (was $-8.5B) — a 25.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cellid, , Ltd. is outperforming or lagging.

The its sector sector average EBIT is about $2.6T. Cellid, , Ltd. is at $-11B, which is lower that average. That is roughly 100.4% below the sector mean. Use the comparison chart on this page to see how 299660.KQ stacks up against individual peers as well.

Tracking 299660.KQ's ebit over time shows whether Cellid, , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $-11B That compares with $-8.5B in the prior-year period — down 25.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Cellid, , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-11B) with ownership activity and broader fundamentals.